Soticlestat (TAK-935/OV935)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Soticlestat (TAK-935/OV935), covering 2021-04-20 to 2021-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY) [Phase 2]